Patients with postacute sequelae of SARS-CoV-2 infection also have circulatory impairment, myalgic encephalomyelitis/chronic fatigue
Rates of COVID-19, Severe Illness Lower With BNT162b2 Booster Dose
Second study shows reduction in rate of death due to COVID-19 with booster dose of BNT162b2
Effectiveness of mRNA COVID-19 Vaccines Lower at ≥120 Days
Among U.S. veterans, VE was 86 percent for Moderna and 75 percent for PfizerBioNTech vaccines at ≥120 days after the second dose
FDA Approves Pfizer Boosters for Teens Aged 16 to 17
Pfizer first sought the approval for using the boosters in this age group at the end of November
200 Million Americans Are Now Fully Vaccinated as COVID-19 Cases Spike
White House officials noted that 12.5 million shots were given last week, the highest weekly total since May
FDA Approves Drug to Help Immunocompromised Fend Off COVID-19
One dose of Evusheld is administered as two separate, consecutive injections and may be effective for six months
Measles Outbreaks May Dominate 2022
The World Health Organization (WHO) and the US Centers for Disease Control and Prevention (CDC) recently warned the global COVID-19 pandemic created both good news as well as ominous measles forecasts.
Published in the CDC’s Morbidity and Mortality Weekly Report in November 2021, the latest immunization, illness, and surveillance trends indicate measles deaths decreased 94% since early 2020.
However, more than twenty-two million infants missed their first dose of the measles vaccine in 2020, about 10% more than in 2019.
Risk Factors ID’d for Postdischarge Thrombosis in COVID-19 Patients
Risk factors for postdischarge VTE include history of VTE, peak D-dimer >3 µg/mL, predischarge CRP >10 mg/dL
U.S. Surgeon General Report Warns of Mental Health Crisis Hitting Youth
Pandemic and other major issues faced by their generation are causing ‘devastating’ mental health effects in young people
Europe Endorses Mixing & Matching COVID-19 Vaccines
The European region is currently experiencing a rising number of SARS-CoV-2 virus infections in the ongoing COVID-19 pandemic and an increase in hospitalization rates.
Unfortunately, only 66.4% of Europeans are fully-vaccinated as of December 7, 2021.
In response, the European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) urge EU citizens to adhere to recent recommendations on COVID-19 booster vaccination.